Takip et
Tilo Grosser
Tilo Grosser
Bielefeld University
itmat.upenn.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser, S Fries, GA FitzGerald
The Journal of clinical investigation 116 (1), 4-15, 2006
13442006
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
TE North, W Goessling, CR Walkley, C Lengerke, KR Kopani, AM Lord, ...
Nature 447 (7147), 1007-1011, 2007
12912007
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ...
Science 296 (5567), 539-541, 2002
10872002
Understanding multicellular function and disease with human tissue-specific networks
CS Greene, A Krishnan, AK Wong, E Ricciotti, RA Zelaya, ...
Nature genetics 47 (6), 569-576, 2015
9272015
Prostanoids in health and disease
EM Smyth, T Grosser, M Wang, Y Yu, GA FitzGerald
Journal of lipid research 50, S423-S428, 2009
6672009
The clinical pharmacology of nonsteroidal antiinflammatory drugs and coxibs.
T Grosser
Applied pharmacokinetics & pharmacodynamics: Principles of therapeutic drug …, 2006
361*2006
Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.
FGGA Yang G, Chen L, Grant GR, Paschos G, Song WL, Musiek ES, Lee V ...
Sci Transl Med 8, 324, 2016
3442016
Antiinflammatory, antipyretic and analgesic agents
T Grosser, EM Smyth, GA FitzGerald
Goodman and Gilman’s the Pharmacological Basis of Therapeutics (12th Edition …, 2011
320*2011
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
KN Theken, CR Lee, L Gong, KE Caudle, CM Formea, A Gaedigk, ...
Clinical Pharmacology & Therapeutics 108 (2), 191-200, 2020
3172020
Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin
T Grosser, S Fries, JA Lawson, SC Kapoor, GR Grant, GA FitzGerald
Circulation 127 (3), 377-385, 2013
3062013
Emotion recollected in tranquility: lessons learned from the COX-2 saga
T Grosser, Y Yu, GA FitzGerald
Annual review of medicine 61 (1), 17-33, 2010
2662010
Developmental expression of functional cyclooxygenases in zebrafish
T Grosser, S Yusuff, E Cheskis, MA Pack, GA FitzGerald
Proceedings of the National Academy of Sciences 99 (12), 8418-8423, 2002
2582002
Celecoxib pathways: pharmacokinetics and pharmacodynamics
L Gong, CF Thorn, MM Bertagnolli, T Grosser, RB Altman, TE Klein
Pharmacogenetics and genomics 22 (4), 310-318, 2012
2412012
The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs
T Grosser, E Ricciotti, GA FitzGerald
Trends in pharmacological sciences 38 (8), 733-748, 2017
2092017
Deciphering the human platelet sheddome
KP Fong, C Barry, AN Tran, EA Traxler, KM Wannemacher, HY Tang, ...
Blood, The Journal of the American Society of Hematology 117 (1), e15-e26, 2011
1982011
Bioinformatic analysis of circadian gene oscillation in mouse aorta
RD Rudic, P McNamara, D Reilly, T Grosser, AM Curtis, TS Price, ...
Circulation 112 (17), 2716-2724, 2005
1822005
Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus
DL Bhatt, T Grosser, J Dong, D Logan, W Jeske, DJ Angiolillo, ...
Journal of the American College of Cardiology 69 (6), 603-612, 2017
1792017
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2
S Fries, T Grosser, TS Price, JA Lawson, S Kapoor, S DeMarco, ...
Gastroenterology 130 (1), 55-64, 2006
1652006
Analysis of the zebrafish proteome during embryonic development
MB Lucitt, TS Price, A Pizarro, W Wu, AK Yocum, C Seiler, MA Pack, ...
Molecular & Cellular Proteomics 7 (5), 981-994, 2008
1632008
Prostanoids and inflammatory pain
L Chen, G Yang, T Grosser
Prostaglandins & other lipid mediators 104, 58-66, 2013
1522013
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20